Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery

Kristian Feterik, Leslie Smith, Zvonimir S Katusic

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The heptapeptide, angiotensin-(1-7), is an active member of the renin-angiotensin system. The present study was designed to characterize the role of endothelium in relaxations of large cerebral arteries to angiotensin-(1-7). Rings of canine middle cerebral arteries were suspended in organ chambers for isometric force recording. The levels of cyclic guanosine 3',5'-monophosphate (cGMP) were assessed by radioimmunoassay. During contraction to uridine 5'-triphosphate (UTP, 3x10-6 to 10-5 mol/l), angiotensin-(1-7) (10-9 to 3x10-5 mol/l) caused concentration-dependent relaxations in arteries with endothelium, but not in endothelium-denuded vessels. Angiotensin-(1-7) significantly increased formation of cGMP. Nitric oxide synthase inhibitor, N-ω-nitro-L-arginine methyl ester (L-NAME, 3x10-4 mol/l), and selective soluble guanylate cyclase inhibitor, 1 H-[1,2,4]oxadiazolo[4,3-a]quinozalin-1-one (ODQ, 3x10-6 mol/l), abolished angiotensin-(1-7)-induced relaxations. Angiotensin receptor antagonists, losartan (10-5 mol/l), PD 123 319 (10-5 mol/l), [Sar1,Thr8]-angiotensin II (10-5 mol/l) [Sar1,Val5,Ala8]-angiotensin II (10-5 mol/l) or [7-D-Ala]-angiotensin 1-7 (10-6 mol/l) did not affect these relaxations. However, angiotensin-converting enzyme inhibitor, captopril (10-5 mol/l) augmented relaxations to angiotensin-(1-7). Finally, bradykinin B2 receptor antagonist, [D-Arg0,Hyp3,Thi5,D-Tic7,Oic8]-bradykinin (HOE 140, 5x10-8 mol/l) significantly reduced the effect of angiotensin-(1-7), while bradykinin B1 receptor antagonist, des-Arg9, [Leu8]-bradykinin (6x10-9 mol/l) did not influence the vascular response to the heptapeptide. These findings indicate that (1) angiotensin-(1-7) produces relaxation of canine middle cerebral arteries by the release of nitric oxide from endothelial cells, (2) angiotensin receptors do not mediate endothelium-dependent relaxations to the heptapeptide, and (3) this effect appears to be dependent on activation of local production of kinins. Our studies support the concept that angiotensin-(1-7), as a natural vasodilator hormone, may counterbalance the hemodynamic actions of angiotensin II. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)75-82
Number of pages8
JournalBrain Research
Volume873
Issue number1
DOIs
StatePublished - Aug 4 2000

Fingerprint

Middle Cerebral Artery
Endothelium
Canidae
Uridine Triphosphate
Cyclic GMP
Angiotensin II
7-Ala-angiotensin (1-7)
Saralasin
angiotensin I (1-7)
Kinins
Angiotensin Receptors
Cerebral Arteries
Losartan
Angiotensin Receptor Antagonists
Captopril
NG-Nitroarginine Methyl Ester
Bradykinin
Renin-Angiotensin System
Vasodilator Agents
Angiotensin-Converting Enzyme Inhibitors

Keywords

  • Angiotensin receptor
  • Bradykinin
  • Cerebral vessel
  • Converting enzyme inhibitor
  • Dogs
  • Nitric oxide

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery. / Feterik, Kristian; Smith, Leslie; Katusic, Zvonimir S.

In: Brain Research, Vol. 873, No. 1, 04.08.2000, p. 75-82.

Research output: Contribution to journalArticle

@article{b053912e3eb449fba90ddaa32a13cec4,
title = "Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery",
abstract = "The heptapeptide, angiotensin-(1-7), is an active member of the renin-angiotensin system. The present study was designed to characterize the role of endothelium in relaxations of large cerebral arteries to angiotensin-(1-7). Rings of canine middle cerebral arteries were suspended in organ chambers for isometric force recording. The levels of cyclic guanosine 3',5'-monophosphate (cGMP) were assessed by radioimmunoassay. During contraction to uridine 5'-triphosphate (UTP, 3x10-6 to 10-5 mol/l), angiotensin-(1-7) (10-9 to 3x10-5 mol/l) caused concentration-dependent relaxations in arteries with endothelium, but not in endothelium-denuded vessels. Angiotensin-(1-7) significantly increased formation of cGMP. Nitric oxide synthase inhibitor, N-ω-nitro-L-arginine methyl ester (L-NAME, 3x10-4 mol/l), and selective soluble guanylate cyclase inhibitor, 1 H-[1,2,4]oxadiazolo[4,3-a]quinozalin-1-one (ODQ, 3x10-6 mol/l), abolished angiotensin-(1-7)-induced relaxations. Angiotensin receptor antagonists, losartan (10-5 mol/l), PD 123 319 (10-5 mol/l), [Sar1,Thr8]-angiotensin II (10-5 mol/l) [Sar1,Val5,Ala8]-angiotensin II (10-5 mol/l) or [7-D-Ala]-angiotensin 1-7 (10-6 mol/l) did not affect these relaxations. However, angiotensin-converting enzyme inhibitor, captopril (10-5 mol/l) augmented relaxations to angiotensin-(1-7). Finally, bradykinin B2 receptor antagonist, [D-Arg0,Hyp3,Thi5,D-Tic7,Oic8]-bradykinin (HOE 140, 5x10-8 mol/l) significantly reduced the effect of angiotensin-(1-7), while bradykinin B1 receptor antagonist, des-Arg9, [Leu8]-bradykinin (6x10-9 mol/l) did not influence the vascular response to the heptapeptide. These findings indicate that (1) angiotensin-(1-7) produces relaxation of canine middle cerebral arteries by the release of nitric oxide from endothelial cells, (2) angiotensin receptors do not mediate endothelium-dependent relaxations to the heptapeptide, and (3) this effect appears to be dependent on activation of local production of kinins. Our studies support the concept that angiotensin-(1-7), as a natural vasodilator hormone, may counterbalance the hemodynamic actions of angiotensin II. Copyright (C) 2000 Elsevier Science B.V.",
keywords = "Angiotensin receptor, Bradykinin, Cerebral vessel, Converting enzyme inhibitor, Dogs, Nitric oxide",
author = "Kristian Feterik and Leslie Smith and Katusic, {Zvonimir S}",
year = "2000",
month = "8",
day = "4",
doi = "10.1016/S0006-8993(00)02482-3",
language = "English (US)",
volume = "873",
pages = "75--82",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery

AU - Feterik, Kristian

AU - Smith, Leslie

AU - Katusic, Zvonimir S

PY - 2000/8/4

Y1 - 2000/8/4

N2 - The heptapeptide, angiotensin-(1-7), is an active member of the renin-angiotensin system. The present study was designed to characterize the role of endothelium in relaxations of large cerebral arteries to angiotensin-(1-7). Rings of canine middle cerebral arteries were suspended in organ chambers for isometric force recording. The levels of cyclic guanosine 3',5'-monophosphate (cGMP) were assessed by radioimmunoassay. During contraction to uridine 5'-triphosphate (UTP, 3x10-6 to 10-5 mol/l), angiotensin-(1-7) (10-9 to 3x10-5 mol/l) caused concentration-dependent relaxations in arteries with endothelium, but not in endothelium-denuded vessels. Angiotensin-(1-7) significantly increased formation of cGMP. Nitric oxide synthase inhibitor, N-ω-nitro-L-arginine methyl ester (L-NAME, 3x10-4 mol/l), and selective soluble guanylate cyclase inhibitor, 1 H-[1,2,4]oxadiazolo[4,3-a]quinozalin-1-one (ODQ, 3x10-6 mol/l), abolished angiotensin-(1-7)-induced relaxations. Angiotensin receptor antagonists, losartan (10-5 mol/l), PD 123 319 (10-5 mol/l), [Sar1,Thr8]-angiotensin II (10-5 mol/l) [Sar1,Val5,Ala8]-angiotensin II (10-5 mol/l) or [7-D-Ala]-angiotensin 1-7 (10-6 mol/l) did not affect these relaxations. However, angiotensin-converting enzyme inhibitor, captopril (10-5 mol/l) augmented relaxations to angiotensin-(1-7). Finally, bradykinin B2 receptor antagonist, [D-Arg0,Hyp3,Thi5,D-Tic7,Oic8]-bradykinin (HOE 140, 5x10-8 mol/l) significantly reduced the effect of angiotensin-(1-7), while bradykinin B1 receptor antagonist, des-Arg9, [Leu8]-bradykinin (6x10-9 mol/l) did not influence the vascular response to the heptapeptide. These findings indicate that (1) angiotensin-(1-7) produces relaxation of canine middle cerebral arteries by the release of nitric oxide from endothelial cells, (2) angiotensin receptors do not mediate endothelium-dependent relaxations to the heptapeptide, and (3) this effect appears to be dependent on activation of local production of kinins. Our studies support the concept that angiotensin-(1-7), as a natural vasodilator hormone, may counterbalance the hemodynamic actions of angiotensin II. Copyright (C) 2000 Elsevier Science B.V.

AB - The heptapeptide, angiotensin-(1-7), is an active member of the renin-angiotensin system. The present study was designed to characterize the role of endothelium in relaxations of large cerebral arteries to angiotensin-(1-7). Rings of canine middle cerebral arteries were suspended in organ chambers for isometric force recording. The levels of cyclic guanosine 3',5'-monophosphate (cGMP) were assessed by radioimmunoassay. During contraction to uridine 5'-triphosphate (UTP, 3x10-6 to 10-5 mol/l), angiotensin-(1-7) (10-9 to 3x10-5 mol/l) caused concentration-dependent relaxations in arteries with endothelium, but not in endothelium-denuded vessels. Angiotensin-(1-7) significantly increased formation of cGMP. Nitric oxide synthase inhibitor, N-ω-nitro-L-arginine methyl ester (L-NAME, 3x10-4 mol/l), and selective soluble guanylate cyclase inhibitor, 1 H-[1,2,4]oxadiazolo[4,3-a]quinozalin-1-one (ODQ, 3x10-6 mol/l), abolished angiotensin-(1-7)-induced relaxations. Angiotensin receptor antagonists, losartan (10-5 mol/l), PD 123 319 (10-5 mol/l), [Sar1,Thr8]-angiotensin II (10-5 mol/l) [Sar1,Val5,Ala8]-angiotensin II (10-5 mol/l) or [7-D-Ala]-angiotensin 1-7 (10-6 mol/l) did not affect these relaxations. However, angiotensin-converting enzyme inhibitor, captopril (10-5 mol/l) augmented relaxations to angiotensin-(1-7). Finally, bradykinin B2 receptor antagonist, [D-Arg0,Hyp3,Thi5,D-Tic7,Oic8]-bradykinin (HOE 140, 5x10-8 mol/l) significantly reduced the effect of angiotensin-(1-7), while bradykinin B1 receptor antagonist, des-Arg9, [Leu8]-bradykinin (6x10-9 mol/l) did not influence the vascular response to the heptapeptide. These findings indicate that (1) angiotensin-(1-7) produces relaxation of canine middle cerebral arteries by the release of nitric oxide from endothelial cells, (2) angiotensin receptors do not mediate endothelium-dependent relaxations to the heptapeptide, and (3) this effect appears to be dependent on activation of local production of kinins. Our studies support the concept that angiotensin-(1-7), as a natural vasodilator hormone, may counterbalance the hemodynamic actions of angiotensin II. Copyright (C) 2000 Elsevier Science B.V.

KW - Angiotensin receptor

KW - Bradykinin

KW - Cerebral vessel

KW - Converting enzyme inhibitor

KW - Dogs

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=0034604779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034604779&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(00)02482-3

DO - 10.1016/S0006-8993(00)02482-3

M3 - Article

C2 - 10915812

AN - SCOPUS:0034604779

VL - 873

SP - 75

EP - 82

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -